Literature DB >> 21710150

Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: a cross-sectional study.

Shanika Nanayakkara1, S T M L D Senevirathna, Upul Karunaratne, Rohana Chandrajith, Kouji H Harada, Toshiaki Hitomi, Takao Watanabe, Tilak Abeysekera, T N C Aturaliya, Akio Koizumi.   

Abstract

BACKGROUND: In the North Central Province of Sri Lanka, chronic kidney disease of uncertain etiology (CKDue) has increased markedly over the past 15-20 years.
METHODS: From around 4,700 patients who were followed up, 106 affected patients who visited two local clinics in the endemic area for CKDue on August 10, 2009 and 10 pedigrees of 10 of these cases with familial clustering of CKDue participated in this study. Urine samples, collected from affected patients (n = 106), unaffected relative controls (n = 81), and Japanese controls (n = 50), were analyzed for two tubular markers: α1-microglobulin and N-acetyl-β-D: -glucosaminidase. Urine samples from patients with CKDue stages 1-4 (n = 101) and all the samples from unaffected relatives and Japanese controls were analyzed for urinary cadmium concentration.
RESULTS: Urinary excretion of α1-microglobulin was elevated even in the earliest stage of CKDue compared with its levels in unaffected relative controls. Urinary excretion of N-acetyl-β-D: -glucosaminidase was elevated only in stage 5. In contrast, urinary cadmium excretion was similar in CKDue patients and in the unaffected relative controls, and levels in both these groups were significantly lower than the level in the Japanese controls. All levels were below the threshold level for renal toxicity, indicating the absence of any evidence of cadmium toxicity.
CONCLUSIONS: The present study indicates that renal tubular damage occurs in the very early stage of CKDue and demonstrates the existence of familial clustering, suggesting that CKDue is likely to be the outcome of exposure to an unknown nephrotoxin in susceptible subjects in the endemic region.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710150      PMCID: PMC3342629          DOI: 10.1007/s12199-011-0224-z

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  27 in total

1.  Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.

Authors:  Etsuko Kobayashi; Yasushi Suwazono; Mirei Uetani; Takeya Inaba; Mitsuhiro Oishi; Teruhiko Kido; Muneko Nishijo; Hideaki Nakagawa; Koji Nogawa
Journal:  Environ Res       Date:  2006-01-24       Impact factor: 6.498

2.  Past, present, and future of environmental specimen banks.

Authors:  Akio Koizumi; Kouji H Harada; Kayoko Inoue; Toshiaki Hitomi; Hye-Ran Yang; Chan-Seok Moon; Peiyu Wang; Nguyen Ngoc Hung; Takao Watanabe; Shinichiro Shimbo; Masayuki Ikeda
Journal:  Environ Health Prev Med       Date:  2009-08-15       Impact factor: 3.674

Review 3.  Chronic kidney disease associated with environmental toxins and exposures.

Authors:  Peter Soderland; Shachi Lovekar; Daniel E Weiner; Daniel R Brooks; James S Kaufman
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

4.  Health effects of cadmium exposure in the general environment in Japan with special reference to the lower limit of the benchmark dose as the threshold level of urinary cadmium.

Authors:  Tsukasa Uno; Etsuko Kobayashi; Yasushi Suwazono; Yasushi Okubo; Katsuyuki Miura; Kiyomi Sakata; Akira Okayama; Hirotsugu Ueshima; Hideaki Nakagawa; Koji Nogawa
Journal:  Scand J Work Environ Health       Date:  2005-08       Impact factor: 5.024

5.  Early diagnosis of endemic nephropathy.

Authors:  D Cvorisćec
Journal:  Clin Chim Acta       Date:  2000-07       Impact factor: 3.786

Review 6.  Alpha 1-microglobulin: clinical laboratory aspects and applications.

Authors:  Joris Penders; Joris R Delanghe
Journal:  Clin Chim Acta       Date:  2004-08-16       Impact factor: 3.786

Review 7.  Understanding the role of genetic polymorphisms in chronic kidney disease.

Authors:  Karin Luttropp; Peter Stenvinkel; Juan Jesús Carrero; Roberto Pecoits-Filho; Bengt Lindholm; Louise Nordfors
Journal:  Pediatr Nephrol       Date:  2008-03-27       Impact factor: 3.714

Review 8.  Common and rare variants in multifactorial susceptibility to common diseases.

Authors:  Walter Bodmer; Carolina Bonilla
Journal:  Nat Genet       Date:  2008-06       Impact factor: 38.330

9.  Alpha-1-microglobulin: an indicator protein for renal tubular function.

Authors:  H Yu; Y Yanagisawa; M A Forbes; E H Cooper; R A Crockson; I C MacLennan
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

10.  Chronic renal failure in North Central Province of Sri Lanka: an environmentally induced disease.

Authors:  Kamani P Wanigasuriya; Roshini J Peiris-John; Rajitha Wickremasinghe; Ariyasena Hittarage
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-07-23       Impact factor: 2.184

View more
  29 in total

Review 1.  Chronic kidney disease of unknown etiology in Sri Lanka.

Authors:  Senaka Rajapakse; Mitrakrishnan Chrishan Shivanthan; Mathu Selvarajah
Journal:  Int J Occup Environ Health       Date:  2016-07-11

2.  Escalating chronic kidney diseases of multi-factorial origin (CKD-mfo) in Sri Lanka: causes, solutions, and recommendations-update and responses.

Authors:  Sunil J Wimalawansa
Journal:  Environ Health Prev Med       Date:  2015-02-19       Impact factor: 3.674

Review 3.  Escalating chronic kidney diseases of multi-factorial origin in Sri Lanka: causes, solutions, and recommendations.

Authors:  Sunil J Wimalawansa
Journal:  Environ Health Prev Med       Date:  2014-09-20       Impact factor: 3.674

Review 4.  The role of ions, heavy metals, fluoride, and agrochemicals: critical evaluation of potential aetiological factors of chronic kidney disease of multifactorial origin (CKDmfo/CKDu) and recommendations for its eradication.

Authors:  Sunil J Wimalawansa
Journal:  Environ Geochem Health       Date:  2015-10-13       Impact factor: 4.609

5.  Whole-exome sequencing reveals genetic variants associated with chronic kidney disease characterized by tubulointerstitial damages in North Central Region, Sri Lanka.

Authors:  Shanika Nanayakkara; S T M L D Senevirathna; Nipuna B Parahitiyawa; Tilak Abeysekera; Rohana Chandrajith; Neelakanthi Ratnatunga; Toshiaki Hitomi; Hatasu Kobayashi; Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2015-06-25       Impact factor: 3.674

Review 6.  CKD of Uncertain Etiology: A Systematic Review.

Authors:  Joseph Lunyera; Dinushika Mohottige; Megan Von Isenburg; Marc Jeuland; Uptal D Patel; John W Stanifer
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 8.237

7.  Quest to identify geochemical risk factors associated with chronic kidney disease of unknown etiology (CKDu) in an endemic region of Sri Lanka-a multimedia laboratory analysis of biological, food, and environmental samples.

Authors:  Keith E Levine; Jennifer Hoponick Redmon; Myles F Elledge; Kamani P Wanigasuriya; Kristin Smith; Breda Munoz; Vajira A Waduge; Roshini J Periris-John; Nalini Sathiakumar; James M Harrington; Donna S Womack; Rajitha Wickremasinghe
Journal:  Environ Monit Assess       Date:  2016-09-03       Impact factor: 2.513

Review 8.  Role of biomarkers of nephrotoxic acute kidney injury in deliberate poisoning and envenomation in less developed countries.

Authors:  Fahim Mohamed; Zoltan H Endre; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

Review 9.  Fluoride in drinking water and diet: the causative factor of chronic kidney diseases in the North Central Province of Sri Lanka.

Authors:  Ranjith W Dharmaratne
Journal:  Environ Health Prev Med       Date:  2015-04-28       Impact factor: 3.674

Review 10.  Genes and environment in chronic kidney disease hotspots.

Authors:  David J Friedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.